Testing the Efficacy of a Post-discharge Call Program on the Rate of Readmission
Sponsor
NYU Langone Health (Other)
Overall Status
Completed
CT.gov ID
NCT03683797
Collaborator
(none)
3,267
1
2
7.3
450
Study Details
Study Description
Brief Summary
NYU Langone Health patients receive a call from a clinical care coordinator after they are discharged from the hospital (within 1-3 days). The current study is testing the efficacy of this program.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Actual Enrollment
:
3267 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Health Services Research
Official Title:
Testing the Efficacy of a Post-discharge Call Program on the Rate of Readmission
Actual Study Start Date
:
Aug 13, 2018
Actual Primary Completion Date
:
Nov 30, 2018
Actual Study Completion Date
:
Mar 22, 2019
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Post-discharge call Patients in this arm will receive a call from a clinical care coordinator after they have been discharged from NYU Langone Health. |
Other: Post-discharge call
Patients will receive a call 1-3 days after they were discharged from the hospital to make sure their healthcare needs are being met.
|
| No Intervention: No post-discharge call Patients in this arm will not receive a call from a clinical care coordinator after they have been discharged from NYU Langone Health. |
Outcome Measures
Primary Outcome Measures
- Rate of readmission [6 months]
Number of patients admitted to a hospital within after being discharged from an earlier hospital stay.
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- All patients discharged from NYU Langone Health who are eligible to receive a call from a clinical care coordinator after they were discharged from the hospital.
Exclusion Criteria:
- N/A
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | New York University School of Medicine | New York | New York | United States | 10016 |
Sponsors and Collaborators
- NYU Langone Health
Investigators
- Principal Investigator: Leora Horwitz, MD, MHS, NYU Langone Health
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
NYU Langone Health
ClinicalTrials.gov Identifier:
NCT03683797
Other Study ID Numbers:
- RCT post-discharge calls
First Posted:
Sep 25, 2018
Last Update Posted:
Jul 20, 2021
Last Verified:
Jul 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No